爱尔康 ALC 深 沪
等待开盘 06-03 09:30:00 美东时间
64.30
-1.410
-2.15%
华盛通- 最 高68.48
- 今 开64.77
- 成交量 210.86万股
- 最 低 61.835
- 昨 收 65.71
- 总市值 3150.70万
- 52周最高 92.55
- 市盈率 静 84.37
- 换手率 430.33%
- 52周最低 61.835
- 委 比 -28.50%
- 总股本 0.00亿
- 历史最高 101.10
- 量 比 0.96
- 振 幅 10.11%
- 历史最低 38.846
- 每 手 1
- 风险率 6.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多欧康维视2025年年报出炉：营收大增92.7%、EBITDA首度转正，平台型眼科龙头迈入盈利新周期
3月26日晚间，欧康维视生物（股票代码：01477.HK）发布2025年业绩。报告期内，公司实现营收8.04亿元，同比大幅增长92.7%；经调整EBITDA为...
03-27 15:30
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.
03-17 21:04
What Analysts Are Saying About Alcon Stock
In the latest quarter, 7 analysts provided ratings for Alcon (NYSE:ALC), showca...
03-09 21:00
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
Earnings Preview: Alcon
Alcon (NYSE:ALC) will release its quarterly earnings report on Tuesday, 2026-02...
02-23 23:01
FDA Expands Approval For Staar Surgical's Popular Implantable Lens
FDA expands Staar Surgical's EVO ICL approval for ages 21-60, offering a safer, non-LASIK alternative to millions.
02-18 18:18
Alcon Announces U.S. Launch Of TOTAL30 Multifocal For Astigmatism
Provides excellent end of day comfort even on day 30,^ helping patients stay in contact lenses†comfortably1Designed for aging eyes, the Water Gradient Material offers 3x greater surface lubricity* and at least 5x
02-17 21:10
Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems
William Blair initiates Alcon with a Market Perform rating, citing strong pipeline, UNITY platform launches, and rising consumables growth, while noting the stock already trades at a premium.
01-31 02:00
STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence
STAAR Surgical shares fell Thursday as new directors joined the board, key leaders exited, and Broadwood Partners pushed for changes following the failed Alcon merger.
01-16 02:06
STAAR Surgical To Terminate Alcon Merger After Failing To Secure Stockholder Approval
STAAR Intends to Terminate Alcon Merger AgreementSTAAR Surgical Company (NASDAQ:STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision
01-06 21:48
